Neuronetics STIM Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Clinical Services | $21.53M— | —— | —— | —— | $18.66M+1,579% | |
| Medical Device | $12.93M— | —— | $37.3M-2.1% | $38.11M+186% | $13.32M-26.2% | |
| Gross Profit by Business | ||||||
| Clinical Services | $6.09M— | —— | —— | —— | $5.57M+1,709% | |
| Medical Device | $10.07M+1,372% | $684K-96.0% | $17.11M-3.7% | $17.76M+74.7% | $10.17M-25.6% | |
| Operating Income by Business | ||||||
| Clinical Services | -$1.86M— | —— | —— | —— | -$2.41M-2,744% | |
| Medical Device | $1.34M-95.5% | $29.64M+505% | -$7.32M+9.1% | -$8.06M-5,825% | -$136K— | |
| Selling General And Administrative Expense by Business | ||||||
| Clinical Services | $7.88M— | —— | —— | —— | $7.93M+3,616% | |
| Medical Device | $7.42M— | —— | —— | —— | $8.74M-22.0% | |
| Research And Development Expense by Business | ||||||
| Clinical Services | $60K— | —— | —— | —— | $51K+1,469% | |
| Medical Device | $1.31M-75.5% | $5.32M+1,557% | $321K-29.9% | $458K-70.7% | $1.57M-85.3% | |
| Cost of Goods Sold by Business | ||||||
| Clinical Services | $15.44M— | —— | —— | —— | $13.09M+1,529% | |
| Medical Device | $2.86M— | —— | $20.19M-0.8% | $20.35M+546% | $3.15M-28.2% | |
| Revenue by Product | ||||||
| Clinic Revenue | $21.53M-8.3% | $23.49M+7.7% | $21.81M-5.3% | $23.02M+23.4% | $18.66M+1,579% | |
| Neuro Star Advanced Therapy System | $3.25M-34.0% | $4.92M+24.4% | $3.96M+8.5% | $3.65M+21.1% | $3.01M-27.9% | |
| Service | $21.53M— | —— | —— | —— | $18.66M+1,579% | |
| Treatment Sessions | $9.25M-28.0% | $12.84M+19.3% | $10.76M-2.7% | $11.05M+13.2% | $9.76M-25.3% | |
| Concentration Risk % by Product | ||||||
| Clinic Revenue | 63%— | —— | 60%-1.0pp | 61%+2.0pp | 59%+57.5pp | |
| Neuro Star Advanced Therapy System | 29%+26.0pp | 3%-50.0pp | 53%+8.0pp | 45%+3.0pp | 42%+41.0pp | |
| Treatment Sessions | 81%+78.0pp | 3%-46.0pp | 49%-42.0pp | 91%+29.0pp | 62%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Neuronetics break its business down?
- Neuronetics (STIM) reports revenue by business across 2 parts — Clinical Services and Medical Device. Each is extracted from the segment footnotes and tracked over time.
- Where does Neuronetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Neuronetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
